- Home
- AMRN
as 11-24-2025 3:07pm EST
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
| Founded: | 1989 | Country: | Ireland |
| Employees: | N/A | City: | DUBLIN 2 |
| Market Cap: | 339.8M | IPO Year: | 1993 |
| Target Price: | $12.00 | AVG Volume (30 days): | 109.8K |
| Analyst Decision: | Strong Sell | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.19 | EPS Growth: | N/A |
| 52 Week Low/High: | $7.08 - $20.90 | Next Earning Date: | 10-29-2025 |
| Revenue: | $226,733,000 | Revenue Growth: | -5.93% |
| Revenue Growth (this year): | -0.78% | Revenue Growth (next year): | -9.66% |
Latest Amarin Corporation plc News
AMRN Breaking Stock News: Dive into AMRN Ticker-Specific Updates for Smart Investing
MT Newswires
6 days ago
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
MT Newswires
7 days ago
European Equities Traded in the US as American Depositary Receipts Down Sharply in Friday Trading
MT Newswires
12 days ago
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Thursday Trading
MT Newswires
14 days ago
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
MT Newswires
15 days ago
European Equities Traded in the US as American Depositary Receipts Start Week Trending Higher in Monday Trading
GlobeNewswire
15 days ago
New REDUCE-IT® Aspirin Analysis Presented at AHA Scientific Sessions 2025 Reinforces VASCEPA®/VAZKEPA® (Icosapent Ethyl) Reduced Cardiovascular Events in High-Risk Patients
MT Newswires
19 days ago
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading
GlobeNewswire
22 days ago
Amarin To Present New Analyses Affirming Robustness of Data from REDUCE-IT and Additional Mechanisms of Action of Eicosapentaenoic Acid (EPA) at American Heart Association (AHA) Scientific Sessions 2025
Compare AMRN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AMRN Amarin Corporation plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.